HOMEOPATHIC MEDICINE IN THE TREATMENT OF ACNE

Cover Page


Cite item

Full Text

Abstract

Background: Systemic medicines for the treatment of acne (antibiotics, retinoids, oral contraceptives) frequently induce adverse events which result in dose reduction or treatment discontinuation and negatively influence treatment efficacy. Chronic application of topical agents may be associated with skin irritation and dermatitis. Thus, there is a constant need for new agents and therapeutic methods producing safe and effective treatment of this commonest skin disorder. Aim: To assess efficacy and tolerability of homeopathic medicine Loma Lux Acnemol in tablets. Materials and methods: 60 patients (age 18–35 years old) with mild and moderate acne were equally divided into two treatment and control groups. During 6 weeks, all patients received routine therapy of acne (sulphur preparations, vitamins, health-promoting therapies); in the treatment group, patients also received homeopathic medicine Loma Lux Acnemol (the dose depended on the body mass). Treatment efficacy criteria included severity of lesion hyperemia, regression of papular rash, absence of new elements and intensity of pain or burning sensation of the skin. Results: Adding Loma Lux Acnemol resulted in significantly better treatment efficacy compared to the routine therapy only: after 6 weeks, clinical improvement was registered in 16 (53.3%) and 6 (20%) patients in the treatment and control groups, respectively; clinical remission was induced in 5 (16.6%) and 7 (23.3%) patients, respectively; evident clinical improvement was absent in 9 (30%) and 12 (40%) cases, respectively. All patients treated with Loma Lux Acnemol reported good tolerability of the medicine; no adverse effects were observed. Conclusion: Homeopathic medicine Loma Lux Acnemol may be recommended for the treatment of mild and moderate acne in young patients.

About the authors

V. G. Kolyadenko

Bogomolets National Medical University; 13 T. Shevchenko bul’var, Kiev, 01601, Ukraine

Author for correspondence.
Email: kvbbogomol@mail.ru
MD, PhD, Professor, the Head of the Department of Dermatovenereology with the Course of AIDS problems Ukraine

D. Ya. Golovchenko

Bogomolets National Medical University; 13 T. Shevchenko bul’var, Kiev, 01601, Ukraine

Email: fake@neicon.ru
MD, PhD, Associate Professor, Department of Dermatovenereology with the Course of AIDS problems Ukraine

L. I. Popova

State Pharmacological Center of the Ministry of Health of Ukraine; 40 Ushinskogo ul., Kiev, 03151, Ukraine

Email: fake@neicon.ru
Senior Research Associate Ukraine

References

  1. Hunter JAA, Savin JA, Dahl MV. Clinical dermatology. Oxford: Blackwell Science Ltd; 1989. 365 p.
  2. Koo J. The psychosocial impact of acne: patients’ perceptions. J Am Acad Dermatol. 1995;32(5 Pt 3):S26–30.
  3. Pochi PE. The pathogenesis and treatment of acne. Annu Rev Med. 1990;41:187–98.
  4. Sykes NL Jr, Webster GF. Acne. A review of optimum treatment. Drugs. 1994;48(1):59–70.
  5. Landow K. Dispelling myths about acne. Post-grad Med. 1997;102(2):94–9, 103–4, 110–2.
  6. Машкиллейсон АЛ, ред. Лечение кожных болезней. Руководство для врачей. М.: Медицина; 1990. 560 с. (Mashkilleyson AL, editor. Treatment of skin diseases. Physician guidance. Moscow: Meditsina; 1990. 560 р. Russian).
  7. Белоусов ЮБ, Моисеев ВС, Липахин ВИ. Клиническая фармакология и фармакотерапия. Руководство для врачей. М.: Универсум Па-блишинг; 1997. 529 с. (Belousov YuB, Moiseev VS, Lipakhin VI. Clinical pharmacology and pharmacotherapy: Physician guidance. Moscow: Universum Pablishing; 1997. 529 p. Russian).
  8. Cunliffe WJ. Strategy of treating acne vulgaris. J Eur Acad Dermatol Venereol. 1992;1:43–52.
  9. Leyden JJ. Therapy for acne vulgaris. N Engl J Med. 1997;336(16):1156–62.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Kolyadenko V.G., Golovchenko D.Y., Popova L.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies